SARS-CoV-2 Eris variant spreads faster and dodges immunity

Study investigates the characteristics of the EG.5.1 “Eris” variant of SARS-CoV-2, finding it more transmissible among hamsters and slightly better at evading immunity compared to the XBB.1.5 variant. The results suggest that these properties could be driving the variant’s increasing prevalence in human populations.

Newly Unveiled Criteria for Pediatric Sepsis Can Improve Diagnoses

PHOENIX — The novel Phoenix sepsis criteria, created by the Society of Critical Care Medicine (SCCM) Pediatric Sepsis Definition Task Force, improved diagnosis of pediatric

January 23, 2024

Huxley Health Inc. Provides Corporate Update – Appoints Bruce Linton as Chairman | Psychedelic Invest

TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) — Huxley Health Inc. (“Huxley” or the “Company”) is pleased to provide you with a comprehensive corporate update, highlighting significant milestones

January 30, 2024

Vir Bio trims staff and pipeline to focus on Sanofi-licensed programmes

Vir expects to save approximately $100m from its “strategic restructuring”, which will be reinvested into the Sanofi-licensed programmes. Image Credit: izzuanroslan / Shutterstock. Vir Biotechnology

August 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.